Gimv N.V.

Gimv N.V.

GIMB.BR
Gimv N.V.BE flagEuronext Brussels
44.65
EUR
-0.75
- -
1.64BMarket Cap
Gimv N.V.
GIMB.BR
(Euronext Brussels)

Recent

price

44.65

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
6.99
45.44
0.93
3
1.97
7.23
7.43
7.63
6.62
6.03
-3.7
10.64
9.48
-0.62
10.57
11.58
Revenue per Share
4.92
4.78
-0.92
1.34
0.6
5.24
5.24
5.03
4.09
4.28
-5.79
7.73
6.4
-2.14
7.56
7.5
Basic EPS, GAAP
1.57
1.18
1.07
-1.9
-0.63
-1.22
-0.92
-3.15
-1.31
-1.35
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
2.29
2.37
2.38
2.33
2.33
2.33
2.38
2.38
2.43
2.43
2.43
1.33
1.34
1.56
1.59
1.26
Dividend per Share
39.74
45.72
42.36
40.75
37.97
40.12
42.62
45.11
46.68
48.47
40.21
45.13
48.34
42.92
47.14
53.76
Book Value per Share
34.37
46.57
42.81
41.81
39.78
42.81
45.6
48.81
51.14
51.42
42.89
48.96
52.31
47.58
51.86
65.29
Tangible Book Value per Share
24
24
24
24
25
26
26
26
26
26
26
27
27
28
29
29
Basic Weighted Avg Shares
167
1,085
22
73
50
188
195
200
174
158
-97
283
258
-17
303
338
Sales/Revenue/Turnover
78
42.21
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
35
36
1
1
1
1
1
1
1
1
2
2
2
2
2
2
Depreciation Expense
118
114
-22
33
15
136
137
132
107
112
-152
206
174
-59
217
219
Net Income, GAAP
0.42
8.86
5.55
5.55
9.92
2.61
2.52
2.3
0.81
2.6
- -
0.02
1.37
- -
0.03
0.22
Effective Tax Rate (%)
70.4
10.53
-99.01
44.73
30.26
72.45
70.52
66.01
61.71
71
156.36
72.66
67.51
346.87
71.57
64.76
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
370
355
- -
- -
- -
- -
- -
- -
- -
- -
253
353
353
353
352
361
LT Debt
1,008
1,112
1,022
1,021
1,003
1,111
1,195
1,279
1,340
1,347
1,124
1,304
1,425
1,325
1,489
1,907
Total Equity
11.24
29.27
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
12.67
11.19
-2.08
3.26
1.54
13.61
12.72
11.48
8.91
8.99
-13.05
18.25
13.84
-4.74
17.04
14.98
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.2%
11.75%
28.03%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-110.18%
-169.88%
0.86%
Sales/Revenue/Turnover
-254.3%
-473.16%
11.46%
Total Cash Common Dividend
- -
-7.25%
-19.2%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
303
2025
- -
- -
- -
- -
338
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
7.56
2025
- -
- -
- -
- -
7.5
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.59
2025
- -
- -
- -
- -
1.26
2026
- -
- -
- -
- -
- -
Business
Gimv NV (GIMB.BR) is a Belgium-based investment company that partners with entrepreneurial management teams of innovative mid-market companies to drive sustainable growth and value creation through private equity and venture capital investments across five strategic platforms: Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities; it deploys capital via its balance sheet and managed funds into buyouts, growth capital, minority stakes, debt, shareholder loans, and venture opportunities targeting firms with enterprise values suited to investments from EUR 5 million to EUR 150 million, focusing on sectors addressing digitalization, electrification, sustainable food, healthcare demographics, and energy transition. Founded in 1980 and headquartered in Antwerp, Belgium, with offices across the Benelux, France, DACH region, and further international presence including the UK, Czech Republic, and Poland, Gimv manages a portfolio of approximately 60 companies generating combined turnover exceeding EUR 4.5 billion and employing over 20,000 professionals, primarily serving business customers in Europe while emphasizing ESG integration, operational excellence, international expansion, innovation, and buy-and-build strategies. Recent developments include investments in the first half of fiscal year 2025 totaling over EUR 300 million across Ambulantis (Healthcare, Germany), Alpine (Consumer, Netherlands), Hemink (Sustainable Cities, Netherlands), and Novicare (Healthcare, Netherlands); a reinvestment in the Bugaboo-Joolz stroller combination post their merger to accelerate global growth; additional capital in Spineart to advance its innovation pipeline and global spine surgery footprint; a strategic partnership with WorxInvest to form Gimv Anchor for long-term anchor investments, starting with Cegeka; a November 2025 minority stake in Equine Care Group alongside CNP and Bencis to fuel international expansion of equine veterinary services; bolt-on acquisitions at portfolio firms like Fronnt, Picot, and EGruppe; and support for TINC's capital increase via Infravest collaboration with Belfius, alongside a net profit of EUR 126.9 million for the first half of FY2025 reflecting solid growth performance.